human normal immunoglobulin
PolandDrugs containing this active substance
-
Cutaquig is used in adults and children to supplement antibody (immunoglobulin) deficiency. It is intended for individuals with primary immunodeficiency (born with a reduced ability to produce antibodies) and individuals with acquired immunodeficiency who experience severe or recurrent infections.
Form: solution for injection
Active substance Dosage human normal immunoglobulin 165 mg/ml ATC: J06BA01
Manufacturer: Octapharma AB Octapharma GmbH Octapharma Pharmazeutika Produktionsges.m.b.H.
-
The medicine is intended for patients with a weakened immune system who have an antibody deficiency and a tendency toward frequent infections. It is used for replacement therapy in individuals with congenital antibody deficiency and in patients with secondary immunodeficiency resulting from other diseases or treatments.
Form: solution for injection
Active substance Dosage human normal immunoglobulin 1 g, 2 g, 4 g or 8 g ATC: J06BA01
Manufacturer: Baxalta Belgium Manufacturing S.A.
-
The medicinal product is used in adults, children, and adolescents for the treatment of antibody deficiencies (both congenital and acquired), prophylaxis of measles in susceptible individuals, and in the treatment of certain autoimmune diseases, such as immune thrombocytopenia, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and severe exacerbations of myasthenia gravis.
Form: solution for infusion
Active substance Dosage human normal immunoglobulin 100 mg/ml ATC: J06BA02
Manufacturer: Instituto Grifols S.A.
-
The medicinal product is used in adults, children, and adolescents to supplement antibody deficiency (in cases of congenital or acquired immunodeficiency) and in the treatment of certain inflammatory diseases, such as immune thrombocytopenia, Guillain-Barré syndrome, Kawasaki disease, or chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy (CIDP and MMN).
Form: solution for infusion
Active substance Dosage human normal immunoglobulin No input provided ATC: J06BA02
Manufacturer: Biotest Pharma GmbH
-
It is used in adults, children, and adolescents for antibody replacement therapy or in the treatment of inflammatory diseases, such as Guillain-Barré syndrome, Kawasaki disease, primary immune thrombocytopenia, or chronic nerve diseases.
Form: solution for infusion
Active substance Dosage human normal immunoglobulin 100 g/l ATC: J06BA02
Manufacturer: Biotest Pharma GmbH
-
The medicinal product is used to treat children, adolescents, and adults with congenital or acquired antibody deficiency. It may also be used in the treatment of certain autoimmune diseases (e.g., immune thrombocytopenia, Kawasaki disease, Guillain-Barré syndrome) and in individuals exposed to measles for whom vaccination is contraindicated.
Form: solution for infusion
Active substance Dosage human normal immunoglobulin 100 mg human normal immunoglobulin No input provided ATC: J06BA02
Manufacturer: Octapharma AB, Octapharma GmbH, Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
-
The medicine is used to increase antibody levels in the blood when they are too low (e.g., in immunodeficiency syndromes) or to treat certain immune-mediated diseases, such as Guillain-Barré syndrome, Kawasaki disease, or immune thrombocytopenia.
Form: solution for infusion
Active substance Dosage human normal immunoglobulin 100 mg/ml ATC: J06BA02
Manufacturer: Prothya Biosolutions Netherlands B.V.